Mission
THE ORGANIZATION'S MISSION IS TO FIND A CURE AND IMPROVE THE QUALITY OF LIFE FOR CHOLANGIOCARCINOMA PATIENTS.
Public Charity
THE CHOLANGIOCARCINOMA FOUNDATION
THE CHOLANGIOCARCINOMA FOUNDATION is a Public Charity headquartered in SALT LAKE CITY, UT. Financial data from the 2025 filing: $7.1M revenue, $7.2M expenses, $5.8M total assets. 72 publicly reported grants to this organization, totaling roughly $5.6M, appear in IRS filings.
EIN: 205776861
SALT LAKE CITY, UT
Medical Research N.E.C.
NTEE: H99
Latest filing: 2025
Total Revenue$7.1M
Total Expenses$7.2M
Total Assets$5.8M
Grant Records72
Funding Total$5.6M
Filing Years2021–2025
Where $100 goes at The Cholangiocarcinoma Foundation
How The Cholangiocarcinoma Foundation divides every $100 it spends, from its own Form 990 filings, averaged across 8 years.
$75
Programs
the work itself
$9
Management
running the organization
$16
Fundraising
raising the next dollar
Inside the $75 for programs
$47
Patient support the organization provides support services to individuals diagnosed with cholangiocarcinoma and their caregivers
$28
Research the organization advances scientific discovery through its research fellowship program, career development award, and innovation grants, which collectively support emerging investigators and fund transformative, high- impact studies
Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
GENERAL SUPPORT
$26,599
For grant recipient's exempt purposes
$332,570
FOR RECIPIENT'S EXEMPT PURPOSE
$279,000
UNRESTRICTED GENERAL SUPPORT
$155,000
GENERAL SUPPORT
$152,673
Showing up to 5 of 72 total records — full history available with membership.
Officers & Directors
COO
Alli Ward
TREASURER
Daniel Blum
BOARD MEMBER
Jack Callaway
BOARD MEMBER
Jason Scott
BOARD MEMBER
Jerry Huang
CHIEF MEDICA
Juan Valle
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $7.1M | $7.2M | $5.8M |
| 2024 | $6.9M | $6.2M | $6.0M |
| 2023 | $5.1M | $5.3M | $4.6M |
| 2022 | $4.9M | $3.6M | $4.0M |
| 2021 | $3.9M | $2.3M | $2.7M |
Between 2021 and 2025, reported annual revenue grew from $3.9M to $7.1M (+83%), with total assets most recently reported at $5.8M.
Interactive year-over-year charts and full filing details available with membership.